Search Results
Results found for "Yanlin Li"
Posts (493)
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
assay and Kd= 42nM in Tag-lite®). Competition experiments of binding of fluorescent ligand CELT-335 to living HEK-293 T cells expressing W.; Wu, Y.; Zhao, S.; Shui, W.; Li, S.; Korde, A.; Laprairie, R. B.; Stahl, E. L.; Ho, J. Cell 2016 , 167 (3), 750-762.e14. https://doi.org/10.1016/j.cell.2016.10.004 . (5) Li, X.; A Fluorescent Ligand-Binding Alternative Using Tag-Lite® Technology.
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
cropped region, not a patch of fluorescence — the entire pancreatic islet , 100–200 microns across, lighting The Moment GPCR Imaging Became a Turning Point Before the islet lit up, the collaboration wasn’t even A ligand-based peptide probe could, offer the consistency and surface selectivity GPCR imaging demands The islet lighting up wasn’t the pinnacle. It was the proof of concept. If JB's story resonates 🎧 Listen to part 1 of this series with Dr.
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
Live-cell high-content screening (HCS) offers an increasingly valuable alternative. By quantifying ligand–receptor interactions directly in intact cells, HCS allows researchers to observe Using HEK-293 cells stably expressing CB2R, fluorescent tracers such as CELT-331 can report on ligand HCS can support CB2 ligand discovery: 1. CB2 ligand characterization.
Other Pages (339)
- Dr. Nicolas Gilles | Dr. GPCR Ecosystem
<< Back to podcast list Dr. GPCR Podcast Strategic Partners Dr. Nicolas Gilles About Dr. His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization Nicolas Gilles on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast? : The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening
- Terry's Corner is Officially LIVE! 🎉 This is your new go-to for mastering drug discovery pharmacology. No fluff, just clear, on-demand insights from Terry Kenakin. Building core expertise? Master dose-response, binding, kinetics, and foundational models. Driving drug discovery? Apply pharmacology to selectivity, ADME, and strategic decision-making. An experienced drug hunter? Sharpen your edge with allosteric bias, residence time, and translational PK/PD. Learn on-demand, apply immediately: https://terrykenakin.com #DrGPCR #GPCR #pharmacology #TerrysCorner #DrugDiscovery | Dr. GPCR Ecosystem
Home → Flash News → Terry's Corner is Officially LIVE! TerrysCorner #DrugDiscovery Published on July 2, 2025 Category Terry's Corner Terry's Corner is Officially LIVE But what if the real opportunity lies in the chemical matter we throw at them?
- 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you’ll learn: ✅ Drug Development Basics – Absorption, metabolism, PK principles ✅ Clearance & Distribution – Renal & hepatic clearance, key pharmacokinetics ✅ PK-PD Modeling – Predicting drug behavior, non-linear PK ✅ Early Drug Safety – Toxicity risks & drug interactions 📌 Spots are filling fast! Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery | Dr. GPCR Ecosystem
Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you – Renal & hepatic clearance, key pharmacokinetics ✅ PK-PD Modeling – Predicting drug behavior, non-linear Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. But what if the real opportunity lies in the chemical matter we throw at them?
Events (2)
- Development of GPCR Ligands as Therapeutic DrugsTickets: $0.00March 20, 2025 | 2:00 PM
- The Practical Assessment of Signaling BiasTickets: $306.48February 20, 2025 | 3:00 PM






